HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.verified

HTGM

Price:

$0.48

Market Cap:

$1.06M

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instrum...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2015-05-06

Stock Exchange

NASDAQ

Ticker

HTGM

The ROE as of September 2024 (TTM) for HTG Molecular Diagnostics, Inc. (HTGM) is -604.85%

According to HTG Molecular Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is -604.85%. This represents a change of 48.27% compared to the average of -407.94% of the last 4 quarters.

HTG Molecular Diagnostics, Inc. (HTGM) Historical ROE (quarterly & annually)

How has HTGM ROE performed in the past?

The mean historical ROE of HTG Molecular Diagnostics, Inc. over the last ten years is 20.11%. The current -604.85% ROE has changed -3107.15% with respect to the historical average. Over the past ten years (40 quarters), HTGM's ROE was at its highest in in the June 2017 quarter at 377.34%. The ROE was at its lowest in in the March 2023 quarter at -1065.28%.

Quarterly (TTM)
Annual

Average

20.11%

Median

-79.26%

Minimum

-400.51%

Maximum

619.70%

HTG Molecular Diagnostics, Inc. (HTGM) ROE by Quarter and Year

Discovering the peaks and valleys of HTG Molecular Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 142.94%

Maximum Annual ROE = 619.70%

Minimum Annual Increase = -467.58%

Minimum Annual ROE = -400.51%

Quarterly (TTM)
Annual
YearROEChange
2022-400.51%142.94%
2021-164.86%14.42%
2020-144.08%78.97%
2019-80.51%3.20%
2018-78.01%-112.59%
2017619.70%33.10%
2016465.59%-467.58%
2015-126.66%-318.15%
201458.06%10.75%
201352.43%-25.06%

HTG Molecular Diagnostics, Inc. (HTGM) Average ROE

How has HTGM ROE performed in the past?

The current ROE of HTG Molecular Diagnostics, Inc. (HTGM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-236.49%

5-year avg

-173.60%

10-year avg

20.11%

HTG Molecular Diagnostics, Inc. (HTGM) ROE vs. Peers

How is HTGM’s ROE compared to its peers?

HTG Molecular Diagnostics, Inc.’s ROE is greater than Genetron Holdings Limited (-36.51%), greater than bioAffinity Technologies, Inc. (-170.13%), greater than Psychemedics Corporation (-69.81%), greater than Precipio, Inc. (-29.31%), greater than Intelligent Bio Solutions Inc. (-205.06%), greater than bioAffinity Technologies, Inc. (-170.13%), less than SeqLL Inc. (-0.04%), greater than Interpace Biosciences, Inc. (-10.70%), greater than Biocept, Inc. (-761.50%), less than T2 Biosystems, Inc. (213.51%), greater than Genetic Technologies Limited (-380.55%),

Build a custom stock screener for HTG Molecular Diagnostics, Inc. (HTGM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HTG Molecular Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HTG Molecular Diagnostics, Inc. (HTGM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HTG Molecular Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is HTG Molecular Diagnostics, Inc.'s ROE?

How is the ROE calculated for HTG Molecular Diagnostics, Inc. (HTGM)?

What is the highest ROE for HTG Molecular Diagnostics, Inc. (HTGM)?

What is the 3-year average ROE for HTG Molecular Diagnostics, Inc. (HTGM)?

What is the 5-year average ROE for HTG Molecular Diagnostics, Inc. (HTGM)?

How does the current ROE for HTG Molecular Diagnostics, Inc. (HTGM) compare to its historical average?